RIVM and EFSA optimise new calculation model for mixture risk assessment Plant protection products (PPPs) are products used in agriculture to protect crops against, for example, fungi, insects and weeds.
Participation rates in cancer population screening programmes continue to decline The number of participants in the population screening programmes for breast cancer, cervical cancer and colorectal cancer continues to decline. This decline has been going on for years, reaching its lowest point in 2020.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
People aged 70 and up invited for repeat vaccination against COVID-19 People aged 70 years and older living in the Netherlands may receive an invitation for a repeat booster against COVID-19 from 26 February 2022 on. They can make an appointment for vaccination by the Municipal Public Health Services (GGDs).
Booster vaccination prevents many hospital and ICU admissions In the period from 26 January to 8 February 2022, the COVID-19 vaccines were 92% effective in preventing hospital admission after the booster, and 55% effective after the basic vaccinations.
Weekly vaccination figures per neighbourhood available through open data As of today, RIVM will publish weekly updates on vaccination turnout and vaccination coverage per neighbourhood in the Netherlands, both cumulative and broken down by calendar week.
Boosters improve diminished protection against Omicron infection after basic COVID-19 vaccination or previous infection Vaccination or previous infection with the coronavirus SARS-CoV-2 provide less effective protection against the Omicron variant compared to the Delta variant. A COVID-19 booster vaccination ensures renewed protection against Omicron.